Assessment of Etest as an alternative to agar dilution for antimicrobial susceptibility testing of Neisseria gonorrhoeae

Journal of Clinical Microbiology

Volumn 52, Issue 5, 2014, Pages 1435-1440

  Liu, Hsi ^a   Taylor Jr , Thomas H ^b   Pettus, Kevin ^a   Trees, David ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; CEFIXIME; CEFPODOXIME; CEFTRIAXONE; ANTIINFECTIVE AGENT;

AGAR DILUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM MUTANT; CONTROLLED STUDY; EPSILOMETER TEST; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL; DISK DIFFUSION; DRUG EFFECTS; GONORRHEA; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; PROCEDURES;

AGAR; ANTI-BACTERIAL AGENTS; DISK DIFFUSION ANTIMICROBIAL TESTS; GONORRHEA; HUMANS; NEISSERIA GONORRHOEAE;

EID: 84899504665     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02131-13     Document Type: Article

References (21)

1. Boslego JW, Tramont EC, Takafuji ET, Diniega BM, Mitchell BS, Small JW, Khan WN, Stein DC. 1987. Effect of spectinomycin use on the prevalence of spectinomycin-resistant and penicillinase-producing Neisseria gonorrhoeae. N. Engl. J. Med. 317:272-278. http://dx.doi.org/10.1056/NEJM198707303170504.
2. Barry PM, Klausner JD. 2009. The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert Opin. Pharmacother. 10:555-557. http://dx.doi.org/10.1517/14656560902731993.
3. Tapsall JW, Ndowa F, Lewis DA, Unemo M. 2009. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev. Anti Infect. Ther. 7:821-834. http://dx.doi.org/10.1586/eri.09.63.
4. Unemo M, Golparian D, Syversen G, Vestrheim DF, Moi M. 2010. Two cases of verified clinical failures using internationally recommended firstline cefixime for gonorrhoea treatment, Norway, 2010. Euro Surveill. 15:pii-19721. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId-19721.
5. Whittington WL, Knapp JS. 1988. Trends in antimicrobial resistance in Neisseria gonorrhoeae in the United States. Sex. Transm. Dis. 15:202-210. http://dx.doi.org/10.1097/00007435-198810000-00006.
6. Workowski KA, Berman SM, Douglas JM, Jr. 2008. Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies. Ann. Intern. Med. 15:606-613. http://dx.doi.org/10.7326/0003-4819- 148-8-200804150-00005.
7. Centers for Disease Control and Prevention. 2007. Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infection. MMWR Morb. Mortal. Wkly. Rep. 56:332-336. http://www.cdc.gov/mmwr/pdf/wk/mm5614.pdf.
8. Centers for Disease Control and Prevention. 2011. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates-United States, 2000-2010. MMWR Morb. Mortal. Wkly. Rep. 60:873-877. http://www.cdc.gov/mmwr/preview/ mmwrhtml/mm6026a2.htm.
9. Chisholm SA, Mouton JW, Lewis DA, Nichols T, Ison CA, Livermore DM. 2010. Cephalosporin MIC creep among gonococci: time for a pharmacodynamics rethink? J. Antimicrob. Chemother. 65:214-218. http://dx.doi.org/10.1093/jac/dkq289.
10. Deguchi T, Yasuda M, Yokoi S, Ishida K, Ito M, Ishihara S, Minamidate K, Harada Y, Tei K, Kojima K, Tamaki M, Maeda S. 2003. Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval. J. Infect. Chemother. 9:35-39. http://dx.doi.org/10.1007/s10156-002-0204-8.
11. Yokoi S, Deguchi T, Ozawa T, Yasuda M, Ito S, Kubota Y, Tamaki M, Maeda S. 2007. Threat to cefixime treatment of gonorrhea. Emerg. Infect. Dis. 13:1275-1277. http://wwwnc.cdc.gov/eid/article/13/8/06-0948-article.htm.
12. Centers for Disease Control and Prevention. 9 January 2013. Gonococcal Isolate Surveillance Project. http://www.cdc.gov/std/gisp/.
13. Baker CN, Stocker SA, Culver DH, Thornsberry C. 1991. Comparison of the E test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria. J. Clin. Microbiol. 29:533-538.
14. Citron DM, Ostovari MI, Karisson A, Goldstein E J C. 1991. Evaluation of the E test for susceptibility testing of anaerobic bacteria. J. Clin. Microbiol. 29:2197-2203.
15. Biedenbach DJ, Jones RN. 1996. Comparative assessment of Etest for testing susceptibilities of Neisseria gonorrhoeae to penicillin, tetracycline, ceftriaxone, cefotaxime, and ciprofloxacin: investigation using 510 (k) review criteria, recommended by the Food and Drug Administration. J. Clin. Microbiol. 34:3214-3217.
16. Singh V, Bala M, Kakran M, Ramesh V. 2012. Comparative assessment of CDS, CLSI disc diffusion and Etest techniques for antimicrobial susceptibility testing of Neisseria gonorrhoeae: a 6-year study. BMJ Open. 2:e000969. http://dx.doi.org/10.1136/bmjopen-2012-000969.
17. Clinical and Laboratory Standards Institute. 2012. Methods for antimicrobial susceptibility testing of anaerobic bacteria: approved standard-8th ed. CLSI document, Approved Standard M11-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
18. Clinical and Laboratory Standards Institute. 2014. Performance standards for antimicrobial susceptibility testing: twenty-third informational supplement. CLSI document, Approved Standard M100-S24. Clinical and Laboratory Standards Institute, Wayne, PA.
19. Centers for Disease Control and Prevention. February 2005. B-88: Neisseria gonorrhoeae reference strains for antimicrobial susceptibility testing. http://www.cdc.gov/std/Gonorrhea/arg/B88-Feb-2005.pdf.
20. Centers for Disease Control and Prevention 2012. Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2010: Oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb. Mortal. Wkly. Rep. 61:590-594. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6131a3.htm.
21. Valdivieso-Garcia A, Imgrund R, Deckert A, Varughese BM, Harris K, Bunimov N, Reid-Smith R, McWen S. 2009. Cost analysis and antimicrobial susceptibility testing comparing the E test and the agar dilution method in Campylobacter jejuni and Campylobacter coli. Diagn. Microbiol. Infect. Dis. 65:168-174. http://dx.doi.org/10.1016/j.diagmicrobio.2009.07.008.